Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cells.
Human interferon from normal diploid fibroblasts, purified by sequential chromatography on concanavalin A-agarose and phenyl-sepharose, was administered parenterally in 4 subjects. Fever, marked skin hypersensitivity reactions and suppression of marrow stem cells (estimated by the count of myeloid colony-forming cells), side-effects common for less purified fibroblast and leukocyte interferons, were absent. Purified fibroblast interferon retained antiviral and immunomodulatory activity, evidenced by reduction of the blastogenic response of peripheral lymphocytes and decrease of hepatitis B virus markers in a patient with chronic hepatitis B infection treated with this substance.
D003114:Colony-Forming Units Assay; D005347:Fibroblasts / Q000276:immunology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006505:Hepatitis / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity; D007372:Interferons / Q000494:pharmacology*; D007958:Leukocyte Count; D008213:Lymphocyte Activation / Q000187:drug effects; D008934:Mitogens / Q000494:pharmacology; D012867:Skin / Q000187:drug effects* / Q000276:immunology; D012882:Skin Tests
D008934:Mitogens; D007372:Interferons